Metis TechBio Co., Ltd. (HKG:7666)
Hong Kong · Delayed Price · Currency is HKD 17.04
-1.33 (-7.24%)
Sep 10, 2026, 1:15 PM HKT
Metis TechBio Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 2,527 | 828.26 | 557.64 | 561.47 | 364.47 |
Short-Term Investments | 232.14 | 267.18 | 21.44 | 279.58 | 20 |
Trading Asset Securities | 115.46 | 30.06 | 209.1 | - | 20.05 |
Cash & Short-Term Investments | 2,875 | 1,126 | 788.18 | 841.05 | 404.52 |
Cash Growth | - | 42.80% | -6.29% | 107.92% | - |
Accounts Receivable | 136.31 | 0.18 | 0.27 | 0.71 | - |
Other Receivables | 0.35 | 0.44 | 3.33 | 175.61 | 5.43 |
Receivables | 136.66 | 0.62 | 3.59 | 176.31 | 5.43 |
Restricted Cash | - | - | - | - | 0.71 |
Other Current Assets | 22.6 | 22.82 | 27.68 | 9.03 | 9.3 |
Total Current Assets | 3,034 | 1,149 | 819.46 | 1,026 | 419.96 |
Property, Plant & Equipment | 82.75 | 93.67 | 72.98 | 105.57 | 173.25 |
Long-Term Investments | 150.44 | - | 107.96 | 125.45 | 10 |
Other Intangible Assets | 3.54 | 4.26 | 5.09 | 6.4 | 1.49 |
Other Long-Term Assets | 43.12 | 43.4 | 43.05 | 49.6 | 12.27 |
Total Assets | 3,314 | 1,290 | 1,049 | 1,313 | 616.98 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 17.93 | 10.61 | 10.69 | 9.36 | 9.61 |
Accrued Expenses | 39.5 | 43.84 | 21.28 | 36.96 | 14.42 |
Current Portion of Long-Term Debt | 40 | 40 | 10 | 30 | 571.85 |
Current Portion of Leases | 18.74 | 18.98 | 16.42 | 17.4 | 1.38 |
Current Income Taxes Payable | 4.37 | 0.6 | 0.61 | 1.77 | 0.86 |
Current Unearned Revenue | 46.51 | 49.19 | 48.08 | - | 4.01 |
Other Current Liabilities | 4.54 | 8.99 | 2.35 | 2.73 | 7.27 |
Total Current Liabilities | 171.58 | 172.21 | 109.43 | 98.21 | 609.4 |
Long-Term Leases | 60.54 | 72.15 | 66.6 | 81.81 | 97.7 |
Long-Term Unearned Revenue | 4.29 | 5.05 | 4.66 | 37.81 | - |
Other Long-Term Liabilities | - | - | 2,250 | 2,073 | - |
Total Liabilities | 296.41 | 249.41 | 2,431 | 2,291 | 707.11 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 118.27 | 94.11 | 87.85 | 87.68 | 111.92 |
Retained Earnings | -1,903 | -1,750 | -1,682 | -1,183 | -601.09 |
Treasury Stock | - | -15.5 | -2,028 | -2,021 | - |
Comprehensive Income & Other | 4,802 | 2,712 | 2,240 | 2,138 | 399.04 |
Shareholders' Equity | 3,018 | 1,041 | -1,382 | -977.56 | -90.13 |
Total Liabilities & Equity | 3,314 | 1,290 | 1,049 | 1,313 | 616.98 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 179.28 | 131.13 | 93.02 | 129.21 | 670.93 |
Net Cash (Debt) | 2,696 | 994.37 | 695.17 | 711.84 | -266.41 |
Net Cash Growth | - | 43.04% | -2.34% | - | - |
Net Cash Per Share | 3.03 | 1.18 | 0.89 | 0.88 | -0.25 |
Filing Date Shares Outstanding | 1,183 | 1,153 | 798.06 | 806.37 | 1,064 |
Total Common Shares Outstanding | 1,183 | 94.11 | 798.06 | 806.37 | 1,064 |
Working Capital | 2,863 | 976.74 | 710.03 | 928.17 | -189.44 |
Book Value Per Share | 2.55 | 11.06 | -1.73 | -1.21 | -0.08 |
Tangible Book Value | 3,014 | 1,037 | -1,387 | -983.96 | -91.62 |
Tangible Book Value Per Share | 2.55 | 11.02 | -1.74 | -1.22 | -0.09 |
Machinery | - | 74.91 | 74.59 | 70.38 | 43.89 |
Construction In Progress | - | 20.94 | - | 1.4 | 36.54 |
Leasehold Improvements | - | 54.45 | 53.39 | 55.14 | 18.01 |